Albion Technology & General VCT PLC Interim Management Statement
Introduction
I am pleased to present Albion Technology & General VCT PLC's interim management
statement for the period from 1 January to 13 May 2011 as required by the UK
Listing Authority's Disclosure and Transparency Rule 4.3.
Performance and dividends
The Company's unaudited net asset value (NAV), based on management accounts, as
at 31 March 2011 was £34.3 million (31 December 2010: £33.1 million) or 86.1
pence per share (excluding treasury shares) (31 December 2010: 85.1p).
The current NAVs and comparative figures are calculated after accounting for the
first dividend for the year to 31 December 2011 of 2.5 pence per share (total
cost: £996,000) which was paid on 28 April 2011 to shareholders on the register
as at 1 April 2011. Shares will be allotted under the Dividend Reinvestment
Scheme in respect of the first dividend for the financial year on 16 May 2011.
After adding back the first dividend for the financial year, the Company's net
asset value has risen by 1 penny per share or 1.2 per cent. since 31 December
2010. This growth in NAV is mainly a result of the issue of share capital under
the Albion VCTs Linked Top Up Offer and an increase in the valuation of the
Company's investment portfolio.
Portfolio
The following investments have been made during the period from 1 January 2011
to 13 May 2011:
+-----------------------------------+------+-----------------------------------+
|Name |£000's|  |
+-----------------------------------+------+-----------------------------------+
|Â | Â |Â |
+-----------------------------------+------+-----------------------------------+
|TEG Biogas (Perth) Limited (new | 544 |Anaerobic digestion plant in |
|investment - total includes total | |Scotland |
|commitment) | | |
+-----------------------------------+------+-----------------------------------+
|Orchard Portman Hospital Limited | 315 |Hospital near Taunton, Somerset, |
|(further investment) | |offering a nursing home for people |
| | |with complex needs |
+-----------------------------------+------+-----------------------------------+
|The Street by Street Solar | 216 |Photo-voltaic installations on |
|Programme Limited (new investment) | |domestic roofs in Maidenhead & |
| | |Windsor |
+-----------------------------------+------+-----------------------------------+
|Nelson House Hospital Limited (new | 205 |Step down rehabilitation hospital |
|investment) | |in Gosport, Hampshire, for men aged|
| | |18-65 with mental health problems |
+-----------------------------------+------+-----------------------------------+
|Masters Pharmaceuticals Limited | 152 |International specialist |
|(further investment) | |distribution of pharmaceuticals |
+-----------------------------------+------+-----------------------------------+
|Opta Sports Data Limited (further | 110 |Leading sports data management |
|investment) | |company |
+-----------------------------------+------+-----------------------------------+
|Xceleron Limited (further | 107 |Provider of a range of drug |
|investment) | |development services to the life |
| | |science industry |
+-----------------------------------+------+-----------------------------------+
|Prime Care Holdings Limited | 72 |Domiciliary care services |
|(further investment) | | |
+-----------------------------------+------+-----------------------------------+
|Regenerco Renewable Energy Limited | 67 |Photo-voltaic installations on |
|(new investment) | |small commercial buildings |
+-----------------------------------+------+-----------------------------------+
|AVESI Limited (new investment) | 54 |Photo-voltaic installations on |
| | |small commercial buildings |
+-----------------------------------+------+-----------------------------------+
Disposals
During the period from 1 January 2011 to 13 May 2011, the following loan stock
repayments were made:
+----------------------------+--------+
| Name | £000's |
+----------------------------+--------+
| Peakdale Molecular Limited | 22 |
+----------------------------+--------+
| CS (Greenwich) Limited | 6 |
+----------------------------+--------+
Top ten qualifying holdings as at 31 March 2011:
+-----------------------------------+----------------+
| Investment | Carrying value |
| | £000's |
+-----------------------------------+----------------+
| Kensington Health Clubs Limited | 2,435 |
+-----------------------------------+----------------+
| Radnor House School Limited | 1,993 |
+-----------------------------------+----------------+
| Dexela Limited | 1,886 |
+-----------------------------------+----------------+
| The Charnwood Pub Company Limited | 1,798 |
+-----------------------------------+----------------+
| Mi-Pay Limited | 1,608 |
+-----------------------------------+----------------+
| Bravo Inns II Limited | 1,339 |
+-----------------------------------+----------------+
| Blackbay Limited | 1,327 |
+-----------------------------------+----------------+
| Helveta Limited | 1,264 |
+-----------------------------------+----------------+
| Xceleron Limited | 1,175 |
+-----------------------------------+----------------+
| Evolutions Group Limited | 1,136 |
+-----------------------------------+----------------+
Albion VCTs Linked Top Up Offer
On 6 April 2011, the Company announced that the Albion VCTs Linked Top Up Offer
would be extended to 16 May 2011 for applications in respect of the tax year to
5 April 2012.
During the period from 1 January to 31 March 2011, the Company issued the
following shares under the Albion VCTs Linked Top Up Offer:
+--------------+---------------------+----------------------+------------------+
|Date | Number of shares |Issue price (per share|Net proceeds £'000|
| | issued |including 5% costs of | |
| | | issue) | |
+--------------+---------------------+----------------------+------------------+
|7 January 2011| 344,862 Ordinary | 94.8 | 302 |
+--------------+---------------------+----------------------+------------------+
|7 January 2011| 440,166 C ordinary | 74.3 | 302 |
+--------------+---------------------+----------------------+------------------+
|22 March 2011 | 360,737 Ordinary | 90.1 | 305 |
+--------------+---------------------+----------------------+------------------+
|22 March 2011 | 463,769 C ordinary | 70.1 | 305 |
+--------------+---------------------+----------------------+------------------+
These amounts have been included in the management accounts figures disclosed
above.
In addition, on 5 April 2011, the following shares were issued under the Top Up
Offer:
+------------+----------------------+-----------------------+------------------+
|Date | Number of shares |Issue price (per share |Net proceeds £'000|
| | issued | including 5% costs of | |
| | | issue) | |
+------------+----------------------+-----------------------+------------------+
|5 April 2011| 474,229 Ordinary | 90.1 | 400 |
+------------+----------------------+-----------------------+------------------+
Material Events and Transactions
As mentioned above, a dividend of 2.5 pence per share was paid on 28 April 2011
to shareholders on the register as at 1 April 2011. The Company will allot
shares under the Dividend Reinvestment Scheme in respect of this dividend on 16
May 2011.
In accordance with the Articles of Association, the C shares converted to
Ordinary shares on 31 March 2011 on the basis of the net assets attributable to
the Ordinary shares and the C shares as disclosed in the audited accounts for
the year to 31 December 2010 and in accordance with the calculation as described
and approved by shareholders' resolution number 4 at the Extraordinary General
Meeting on 8 December 2005. C shareholders have therefore received 0.7779
Ordinary shares for each C share they used to own.
During the period from 1 January 2011 to 31 March 2011, the Company purchased
233,000 Ordinary shares at an average price of 76.6 pence per share and 337,300
C shares at an average price of 59.1 pence per share. These shares will be held
in treasury. Since the conversion of C shares to Ordinary shares on 31 March
2011, the Company has made no share buybacks.
The Company continues to offer a Dividend Reinvestment Scheme to existing
shareholders. Details of this Scheme can be found at www.albion-
ventures.co.uk/Our Funds/Albion Technology & General VCT PLC.
There have been no further significant events or transactions that the Board is
aware of which would have a material impact on the financial position of the
Company between 1 January 2011 and 13 May 2011.
Further information regarding historic and current financial performance and
other useful shareholder information can be found on the Fund's website under
www.albion-ventures.co.uk/Our Funds/Albion Technology & General VCT PLC.
Dr. Neil Cross, Chairman
13 May 2011
For further information please contact:
Patrick Reeve, Albion Ventures LLP - tel: 020 7601 1850
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Albion Technology & General VCT PLC - Ordinary Shares via Thomson Reuters ONE
[HUG#1515762]
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.